ADMA Biologics Inc (NASDAQ:ADMA)

2.05
BATS BZX Real-Time Price
As of 3:50pm ET
 -0.025 / -1.21%
Today’s Change
1.01
Today|||52-Week Range
2.38
+45.04%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$420.2M

Company Description

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Contact Information

ADMA Biologics, Inc.
465 State Route 17 South
Ramsey New Jersey 07446
P:(201) 478-5552
Investor Relations:

Employees

Shareholders

Other institutional49.00%
Individual stakeholders27.35%
Mutual fund holders11.92%

Top Executives

Adam S. GrossmanPresident, Chief Executive Officer & Director
Atkinson VernonOperations Director
Brian LenzChief Financial Officer & Executive Vice President
Kaitlin KestenbergVice President-Compliance & Clinical Operations
Kevin WeeksSenior Director-Facilities & Engineering